Fully human heavy chain variable region and modified constant region

Robust immune response compared with RenMab mouse

Diversity of the antigen-specific antibodies discovered from RenNano

High binding affinity at nanomolar range

Good developability

Posters

AACR 2023: RenNano^® Mice: A Heavy-Chain-Only Antibody Platform for the Generation of Nanobody Therapeutics